Views

Primary care networks are bonkers. It’s old thinking, old ways of failure and old strategy, says Sid Dajani. 

The apprenticeship trailblazer group is still unknown. Boots, Well, Lloydspharmacy, Superdrug...what a reticent bunch!

Does the apprenticeship trailblazer group really think pharmacists shouldn't diagnose and manage care, asks Claire Ward.

Negativity has greeted apprenticeships. Is this because people don’t understand them, asks Pharmacist Spectator.

Posts on the Women in Pharmacy Facebook group show that members still face discrimination, says Deborah Evans.

It was as well Kleenex rebranded its ‘man-size’ tissues before someone reported their pharmacist to the trading standards office.  

What can pharmacists learn from stand-up comedy and sports psychology to help them cope with unannounced GPhC inspections?

As the Royal Pharmaceutical Society’s star wanes, the Pharmacist’s Defence Association’s rises, says our correspondent. 

A debate about the serious shortage protocols exposed MPs' ignorance about pharmacists' expertise in medicines.

Other large companies realise it is a matter of time before their pharmacists seek the benefits of being a member of a trade union.

When our reality is greater than our expectations, we are happy. This might be why many pharmacists are unhappy...

The GPhC’s answer to our plight is more regulation, pressure, targets and rising fees, says Sid Dajani. 

The long-term plan has lots of ideas about improving the NHS but no mention of getting rid of prescription charges...

As Brexit drags on, pharmacists are being placed between a rock and a hard place.

Frustration with NHS waiting lists has seen more people pay for their own healthcare. Should pharmacies take note?

Nobody can guess the future because it is too volatile to predict, says Sid Dajani.

With proper leadership from government and pharmacy bodies, pharmacies’ place on the high street could be secured.

Securing a place on STP boards is achievable for LPCs - although it is hit and miss across the country. 

The health secretary Matt Hancock is well known for his interest and enthusiasm for anything digital.

Steve Ainsworth explores the origins of the compound ergot, which in modern times became a source for pharmaceutical drugs